Government approves new Down’s syndrome test – BBC News

Image copyright SPL

Women that are pregnant in England will quickly be provided a much safer, better new test for Down’s syndrome, government ministers have confirmed.

The non-invasive prenatal test (NIPT) is going to be folded by the NHS from 2018.

It ought to cut the amount of ladies who need riskier tests during pregnancy that induce a miscarriage.

But critics fear the brand new test, although optional, may have an undesirable effect – more women aborting Down’s babies.

A world without Down’s syndrome?

Down’s syndrome is really a genetic condition that typically causes some degree of learning disability and characteristic physical features.

The NHS already offers screening to women 11 to 14 days to their pregnancy.

Diagnosing Down’s

Right now, an ultrasound scan, your age along with other factors for example smoking are combined to evaluate the probability of an infant getting Down’s.

Anybody having a more than one-in-150 possibility of having a baby to some baby using the condition is provided an amniocentesis, where a needle can be used to extract an example of amniotic fluid all around the foetus for testing to obtain a obvious diagnosis.

It’s a dangerous procedure and the majority of the ladies who are referred for amniocentesis won’t have an infant with Down’s. Yet one out of every 100 that has the exam risks getting a miscarriage.

NIPT is a straightforward bloodstream test that may more precisely inform women concerning the likelihood of their unborn baby getting Down’s, or indeed other genetic disorders for example Edwards’ and Patau’s syndromes, before deciding if you should have amniocentesis.

Image copyright SPL
Image caption Amniocentesis increases the chance of getting a miscarriage

Experts estimate NIPT could avoid greater than 6,000 of those invasive procedures every year. Which means that there might be a decrease in the amount of miscarriages associated with amniocentesis from 46 to roughly three each year.

Some non profit organizations and patient organisations have welcomed the move, but other medication is worried about the potential ramifications.

Individuals with Down’s syndrome, their own families and campaign groups expressed anger at not consulted before the choice to unveil the screening.

The Nuffield Council on Bioethics is presently thinking about the plethora of ethical issues elevated through the new make sure will publish its findings at the begining of 2017.

Dr Anne Mackie, in the United kingdom National Screening Committee, stated: “We’ll carefully manage the roll-from non-invasive prenatal testing to provide us a much better knowledge of the outcome it’s around the decisions ladies and their partners make following their test results.

“Answer to making certain we obtain this right may be the work we’re doing with patient groups, scientists and clinicians, to assist us develop balanced informative sources for that public and health care professionals.Inch

Find out more: http://www.bbc.co.uk/news/health-37824048